Loading...
Receive $200 for creating an Interactive Brokers account using our link: Create IBKR account. Read our Interactive Brokers analysis
- Ticker
- AKBM.OL
- Price
- 106.00
- Stock movement up
- +3.80 (3.63%)
- Company name
- Aker Biomarine AS
- Exchange
- (OL ,
- Currency
- NOK )
- Sector
- Consumer Defensive >Packaged Foods
- Market cap
- 9.51B
- Ent value
- -
- Price/Sales
- 12.94
- Price/Book
- 66.07
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- 429.65
- PEG
- -
- EPS growth
- 30.12%
- 1 year return (CAGR)
- 66.51%
- 3 year return (CAGR)
- 40.84%
- 5 year return (CAGR)
- -0.65%
- 10 year return (CAGR)
- 30.62%
Last updated: 2026-03-10
DIVIDENDS
AKBM.OL does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | 206.49 |
| Price to FCF | - |
| Price to EBITDA | 71.51 |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 12.94 |
| Price to Book | 66.07 |
| EV to Sales | - |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 87.70M |
| EPS (TTM) | -0.23 |
| FCF per share (TTM) | -0.28 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 734.81M |
| Gross profit (TTM) | 274.94M |
| Operating income (TTM) | 132.73M |
| Net income (TTM) | -20.07M |
| EPS (TTM) | -0.23 |
| EPS (1y forward) | 0.25 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 37.42% |
| Operating margin (TTM) | 18.06% |
| Profit margin (TTM) | -2.73% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 0.00 |
| Net receivables | 0.00 |
| Total current assets | 190.10M |
| Goodwill | 0.00 |
| Intangible assets | 116.90M |
| Property, plant and equipment | 0.00 |
| Total assets | 384.90M |
| Accounts payable | 0.00 |
| Short/Current long term debt | 0.00 |
| Total current liabilities | 77.00M |
| Total liabilities | 241.00M |
| Shareholder's equity | 143.90M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | 46.04M |
| Capital expenditures (TTM) | 29.87M |
| Free cash flow (TTM) | -24.53M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -13.95% |
| Return on Assets | -5.21% |
| Return on Invested Capital | -6.62% |
| Cash Return on Invested Capital | -8.09% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 105.40 |
| Daily high | 111.80 |
| Daily low | 105.40 |
| Daily Volume | 40K |
| All-time high | 127.96 |
| 1y analyst estimate | 69.07 |
| Beta | 0.36 |
| EPS (TTM) | -0.23 |
| Dividend per share | 0.00 |
| Ex-div date | 9 Sep 2024 |
| Next earnings date | 28 Apr 2026 |
Downside potential
Loading...
Downside potential data
| AKBM.OL | S&P500 | |
| Current price drop from All-time high | -17.16% | -1.82% |
| Highest price drop | -99.21% | -56.47% |
| Date of highest drop | 13 Aug 2012 | 9 Mar 2009 |
| Avg drop from high | -67.58% | -10.84% |
| Avg time to new high | 229 days | 12 days |
| Max time to new high | 3655 days | 1805 days |
COMPANY DETAILS
Marketcap
9.51B
Marketcap category
Mid-cap
Description
Aker BioMarine ASA, a biotech innovator, develops and supplies krill-derived products for consumer health and wellness worldwide. It operates through three segments: Human Health Ingredients (HHI), Consumer Health Products, and Emerging Business. The Human Health Ingredients segment sells B2B krill oil supplements for humans under the Superba Krill brand; supplements for brain health under the LYSOVETA brand; and marine-origin DHA omega-3 from microalgae under the Revervia brand name, as well as advanced phospholipid technology under PL+ name. The Consumer Health Products segment sells processed and packaged krill, fish, and plants derived raw materials to retailers in the United States. The Emerging Business segment offers krill oil under Kori brand name. The company provides protein solutions under the Understory brand; biostimulants under KRBNX brand; and a therapeutic candidate based on omega-3 to manage and treat cardiometabolic diseases under CaPre brand name, as well as delivers circular products utilizing recycled industrial and marine plastic waste under AION name. Aker BioMarine ASA was founded in 2006 and is headquartered in Lysaker, Norway. Aker BioMarine ASA is a subsidiary of Aker ASA.
Employees
249
Investor relations
-
SEC filings
CEO
Country
Norway
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
Aker BioMarine ASA (FRA:1PG) reports a robust quarter with significant gains in Human Health Ingredients, despite facing hurdles in Consumer Health Products.
February 18, 2026
As the pan-European STOXX Europe 600 Index edges closer to record highs, buoyed by optimism around future earnings and economic prospects, investors are increasingly on the lookout for opportunities t...
January 2, 2026
As the pan-European STOXX Europe 600 Index recently rose by 1.60%, buoyed by signs of steady economic growth and looser monetary policy, investors are keenly observing opportunities in the region. In ...
December 23, 2025
As European markets experience a positive turn, with the STOXX Europe 600 Index climbing 1.60% amid signs of steady economic growth and supportive monetary policies, investors are increasingly keen on...
December 22, 2025
As European markets continue to show signs of steady economic growth, with the pan-European STOXX Europe 600 Index rising by 1.60%, investors are increasingly on the lookout for opportunities that may...
December 22, 2025
As European markets navigate a period of mixed performance, with the pan-European STOXX Europe 600 Index ending slightly lower and varied results across major indices like Germany’s DAX and France’s C...
December 18, 2025
As European markets show mixed returns, with the STOXX Europe 600 Index edging higher on hopes of interest rate cuts, investors are keenly analyzing opportunities in value stocks trading below their e...
December 11, 2025
As European markets navigate mixed returns with the STOXX Europe 600 Index inching higher amid hopes for interest rate cuts, investors are keenly observing economic indicators like the uptick in euroz...
December 11, 2025
As of late November 2025, European markets have seen a notable upswing, with the pan-European STOXX Europe 600 Index rising by 2.35% and major single-country indexes also posting gains. This positive ...
December 4, 2025
As European markets continue to experience positive momentum, with the pan-European STOXX Europe 600 Index closing 2.35% higher and major single-country indexes also rising, investors are keenly watch...
December 4, 2025
Next page